However, in recent loss-of-function studies using RNA interference (RNAi) and/or CRISPR genome editing technology, circadian molecular functions involving the core clock transcriptional activators CLOCK and/or BMAL1 have proven to be required for the maintenance of CSC/EMT properties in cancer cells [123,128,129]. The gene discussed is CLOCK; the disease is cancer.